Application no. and date | 99939130.3 (espacenet) (Federated) (European Patent Register), 19990811 | Patent/reg. no. and date | DK/EP 1128834, 20050427 | Publication date | 20010905 | Priority no. and date | US 189132, 19981109 | EP pub. no. and date |
EP 1128834 20010905 | Effective date | | Applicant/owner | Warner-Lambert Company LLC, 235 East 42nd Street New York, NY 10017, US | Applicant ref. no. | 122650 | Inventor | WHITCOMB, Randall, W., 1527 High Hollow Drive
Ann Arbor, MI 48103, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/155 (2006.01) , A61K 31/427 (2006.01) , A61K 31/64 (2006.01) , A61P 3/08 (2006.01) | Title | Kombinationer til diabetes, som indeholder glyburid, troglitazon (og et biguanid) | Int. application no. | US1999018140 | Int. publication no. | WO2000027401 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|